Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
* S.Africa has paused AstraZeneca vaccinations* Vaccine less effective vs local variant -trial* To start immunisations with J&J doses instead* Small amounts of J&J to arrive initially* Rollout will be in study form with researchers (Adds details)By ...
10 Feb 21 06:17* S.Africa has paused AstraZeneca vaccinations* Vaccine less effective vs local variant -trial* To start immunisations with J&J doses instead* Small amounts of J&J to arrive initially* Rollout will be in study form with researchers (Adds WHO panel, ...
10 Feb 21 06:17(Adds comment from Peru's president)By Marco AquinoLIMA, Feb 9 (Reuters) - Peru launched its COVID-19 vaccination campaign on Tuesday with newly arrived doses of China's Sinopharm vaccine, as the South American country struggles to control a fierc...
10 Feb 21 01:13(Adds quote, detail, context)By Lunga MasukuMBABANE, Feb 9 (Reuters) - eSwatini will no longer use AstraZeneca's COVID-19 vaccine, its health minister said on Tuesday, after a trial showed it gave minimal protection against mild-to-moderate COVID-...
9 Feb 21 18:38MBABANE, Feb 9 (Reuters) - eSwatini Health Minister Lizzie Nkosi said on Tuesday that her country, which borders South Africa, would no longer use AstraZeneca's COVID-19 vaccine.South Africa has put on hold the rollout of AstraZeneca's vaccine, a...
9 Feb 21 17:43(Adds German health ministry, background)By Michael NienaberBERLIN, Feb 9 (Reuters) - Germany is planning to spend nearly 9 billion euros ($10.9 billion) this year to help procure up to 635.1 million COVID-19 vaccination shots for its population a...
9 Feb 21 16:53(Repeats to attach to alerts)GENEVA, Feb 9 (Reuters) - AstraZeneca's Chief Executive said on Tuesday that the results of a study showing its COVID-19 vaccine had little effect against mild disease were concerning but stressed that it should work a...
9 Feb 21 13:23GENEVA, Feb 9 (Reuters) - AstraZeneca's Chief Executive said on Tuesday that the results of a study showing its COVID-19 vaccine had little effect against mild disease were concerning but stressed that it should work against severe forms."It is o...
9 Feb 21 12:48(Sharecast News) - World Health Organization scientists who have been studying the origin of the Covid-19 virus in China over the past four weeks concluded that the most likely origin of the illness was in animals.
9 Feb 21 11:55(Adds more comments)BUDAPEST, Feb 9 (Reuters) - Hungary will start vaccinating people suffering no chronic diseases with Russia's Sputnik COVID-19 vaccine soon, the surgeon general said on Tuesday, becoming the first European Union country to use...
9 Feb 21 11:36(Adds details)By Michael NienaberBERLIN, Feb 9 (Reuters) - Germany is planning to spend nearly 9 billion euros ($10.9 billion) this year to buy up to 635.1 million COVID-19 vaccines as part of the European Union's procurement scheme and national d...
9 Feb 21 11:29(Adds background)By Michael NienaberBERLIN, Feb 9 (Reuters) - Germany is planning to spend nearly 9 billion euros ($10.9 billion) this year to help procure up to 635.1 million COVID-19 vaccination shots for its population and other EU member state...
9 Feb 21 11:29NEW DELHI, Feb 9 (Reuters) - Johnson & Johnson is interested in manufacturing its COVID-19 vaccine in India, a government official told a news conference on Tuesday.India also currently has no concern over the efficacy of the AstraZeneca vaccine t...
9 Feb 21 11:18(Sharecast News) - It remains to be seen whether the world needs new vaccines to fend off the new strains of novel coronavirus, a top researcher said.
9 Feb 21 09:29(Adds quotes, details)By Dominique VidalonPARIS, Feb 9 (Reuters) - The COVID-19 situation in France is currently stable and the government was right to have decided against imposing a new national lockdown, Health Minister Olivier Veran said on Tu...
9 Feb 21 09:19
Last checked at